Drugs For ADPKD Article 01. Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD. 02. Drug repurposing in autosomal dominant polycystic kidney disease. 03. Therapeutic advances in ADPKD: the future awaits. 04. Polycystic Kidney Disease Drug Development: A Conference Report. 05. Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial. 06. Tolvaptan in patients with autosomal dominant polycystic kidney disease. 07. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. 08. Initial eGFR Changes Predict Response to Tolvaptan in ADPKD.